These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 28518053

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Polymorphism of ORM1 is associated with the pharmacokinetics of telmisartan.
    Chen WQ, Shu Y, Li Q, Xu LY, Roederer MW, Fan L, Wu LX, He FZ, Luo JQ, Tan ZR, He YJ, Zhou HH, Chen X, Zhang W.
    PLoS One; 2013; 8(8):e70341. PubMed ID: 23940561
    [Abstract] [Full Text] [Related]

  • 5. Effects of UGT1A1 Polymorphism, Gender and Triglyceride on the Pharmacokinetics of Telmisartan in Chinese Patients with Hypertension: A Population Pharmacokinetic Analysis.
    Huang L, Yang L, Huang J, Tan HY, Liu SK, Guo CX, Zuo XC, Yang GP, Pei Q.
    Eur J Drug Metab Pharmacokinet; 2019 Dec; 44(6):797-806. PubMed ID: 31254178
    [Abstract] [Full Text] [Related]

  • 6. Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients.
    Miura M, Kagaya H, Satoh S, Inoue K, Saito M, Habuchi T, Suzuki T.
    Ther Drug Monit; 2008 Oct; 30(5):559-64. PubMed ID: 18695635
    [Abstract] [Full Text] [Related]

  • 7. The association of the UGT1A8, SLCO1B3 and ABCC2/ABCG2 genetic polymorphisms with the pharmacokinetics of mycophenolic acid and its phenolic glucuronide metabolite in Chinese individuals.
    Geng F, Jiao Z, Dao YJ, Qiu XY, Ding JJ, Shi XJ, Li ZD, Zhong MK.
    Clin Chim Acta; 2012 Apr 11; 413(7-8):683-90. PubMed ID: 22227166
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic and pharmacogenomic profiles of telmisartan after the oral microdose and therapeutic dose.
    Ieiri I, Nishimura C, Maeda K, Sasaki T, Kimura M, Chiyoda T, Hirota T, Irie S, Shimizu H, Noguchi T, Yoshida K, Sugiyama Y.
    Pharmacogenet Genomics; 2011 Aug 11; 21(8):495-505. PubMed ID: 21691256
    [Abstract] [Full Text] [Related]

  • 9. Association Between ABCG2, ABCB1, ABCC2 Efflux Transporter Single-Nucleotide Variants and Irinotecan Adverse Effects in Patients With Colorectal Cancer: A Real-Life Study.
    Barnett-Griness O, Rennert G, Lejbkowicz F, Pinchev M, Saliba W, Gronich N.
    Clin Pharmacol Ther; 2023 Mar 11; 113(3):704-711. PubMed ID: 36537755
    [Abstract] [Full Text] [Related]

  • 10. The impact of pharmacogenetics of metabolic enzymes and transporters on the pharmacokinetics of telmisartan in healthy volunteers.
    Yamada A, Maeda K, Ishiguro N, Tsuda Y, Igarashi T, Ebner T, Roth W, Ikushiro S, Sugiyama Y.
    Pharmacogenet Genomics; 2011 Sep 11; 21(9):523-30. PubMed ID: 21829131
    [Abstract] [Full Text] [Related]

  • 11. ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects.
    Cao K, Ren G, Lu C, Wang Y, Tan Y, Zhou J, Zhang Y, Lu Y, Li N, Chen X, Zhao D.
    Eur J Clin Pharmacol; 2020 Jan 11; 76(1):51-59. PubMed ID: 31677118
    [Abstract] [Full Text] [Related]

  • 12. Serum bilirubin concentration in healthy adult North-Europeans is strictly controlled by the UGT1A1 TA-repeat variants.
    Kringen MK, Piehler AP, Grimholt RM, Opdal MS, Haug KB, Urdal P.
    PLoS One; 2014 Jan 11; 9(2):e90248. PubMed ID: 24587300
    [Abstract] [Full Text] [Related]

  • 13. Effects of splicing-regulatory polymorphisms in ABCC2, ABCG2, and ABCB1 on methotrexate exposure in Chinese children with acute lymphoblastic leukemia.
    Li M, Kong XY, Wang SM.
    Cancer Chemother Pharmacol; 2023 Jan 11; 91(1):77-87. PubMed ID: 36463535
    [Abstract] [Full Text] [Related]

  • 14. Influence of SLCO1B1, 1B3, 2B1 and ABCC2 genetic polymorphisms on mycophenolic acid pharmacokinetics in Japanese renal transplant recipients.
    Miura M, Satoh S, Inoue K, Kagaya H, Saito M, Inoue T, Suzuki T, Habuchi T.
    Eur J Clin Pharmacol; 2007 Dec 11; 63(12):1161-9. PubMed ID: 17906856
    [Abstract] [Full Text] [Related]

  • 15. Impact of ABCB1, ABCC1, ABCC2, and ABCG2 variants in predicting prognosis and clinical outcomes of north Indian lung cancer patients undergoing platinum-based doublet chemotherapy.
    Sharma P, Singh N, Sharma S.
    J Gene Med; 2023 Jan 11; 25(1):e3460. PubMed ID: 36314103
    [Abstract] [Full Text] [Related]

  • 16. Association of genetic polymorphisms in the influx transporter SLCO1B3 and the efflux transporter ABCB1 with imatinib pharmacokinetics in patients with chronic myeloid leukemia.
    Yamakawa Y, Hamada A, Nakashima R, Yuki M, Hirayama C, Kawaguchi T, Saito H.
    Ther Drug Monit; 2011 Apr 11; 33(2):244-50. PubMed ID: 21311410
    [Abstract] [Full Text] [Related]

  • 17. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.
    Tian C, Ambrosone CB, Darcy KM, Krivak TC, Armstrong DK, Bookman MA, Davis W, Zhao H, Moysich K, Gallion H, DeLoia JA.
    Gynecol Oncol; 2012 Mar 11; 124(3):575-81. PubMed ID: 22112610
    [Abstract] [Full Text] [Related]

  • 18. ABCB1 gene polymorphisms, ABCB1 haplotypes and ABCG2 c.421c > A are determinants of inter-subject variability in rosuvastatin pharmacokinetics.
    Zhou Q, Ruan ZR, Yuan H, Xu DH, Zeng S.
    Pharmazie; 2013 Feb 11; 68(2):129-34. PubMed ID: 23469685
    [Abstract] [Full Text] [Related]

  • 19. Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer.
    Zhou Q, Sparreboom A, Tan EH, Cheung YB, Lee A, Poon D, Lee EJ, Chowbay B.
    Br J Clin Pharmacol; 2005 Apr 11; 59(4):415-24. PubMed ID: 15801936
    [Abstract] [Full Text] [Related]

  • 20. Influence of CYP3A4/5 and ABC transporter polymorphisms on lenvatinib plasma trough concentrations in Japanese patients with thyroid cancer.
    Ozeki T, Nagahama M, Fujita K, Suzuki A, Sugino K, Ito K, Miura M.
    Sci Rep; 2019 Apr 01; 9(1):5404. PubMed ID: 30931962
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.